| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Emergent Biosolutions Inc. (EBS) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. EBS is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 305.4K | $2.54M | - | |
| CFO | 215.4K | $1.79M | - | |
| Dir | 119.9K | $998.4K | - | |
| VP | 104.1K | $867.2K | - | |
| Dir | 89.0K | $741.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 21, 2020 | Richard Ronald | Director | Sale+OE | 5,152 | $65.00 | $334,880.00 | -23.9% | |
| Feb 21, 2020 | Hauer Jerome M | Director | Sell | 6,572 | $70.00 | $460,040.00 | -35.9% | |
| Feb 21, 2020 | El-Hibri Fuad | Chairman | Sale+OE | 23,318 | $64.90 | $1,513,338.20 | -0.8% | |
| Feb 18, 2020 | El-Hibri Fuad | Chairman | Sale+OE | 20,000 | $63.90 | $1,278,000.00 | -0.7% | |
| Feb 12, 2020 | El-Hibri Fuad | Chairman | Sale+OE | 20,000 | $62.90 | $1,258,000.00 | -0.7% | |
| Feb 6, 2020 | El-Hibri Fuad | Executive Chairman | Sell | 60,000 | $60.90 | $3,654,088.16 | -2.1% | |
| Jan 16, 2020 | Harsanyi Zsolt | Director | Sell | 3,435 | $55.00 | $188,925.00 | -8.7% | |
| Dec 12, 2019 | Bailey Sue | Director | Sell | 8,375 | $53.46 | $447,727.50 | -15.3% | |
| Nov 18, 2019 | Zoon Kathryn C62 | Director | Sell | 1,000 | $54.31 | $54,314.00 | -5.4% | |
| Nov 8, 2019 | Zoon Kathryn C62 | Director | Sell | 3,082 | $54.15 | $166,884.44 | -14.3% |